Title: Measurable residual disease in children with acute lymphoblastic leukemia treated with non-MRD based protocol, what we are missing? : experience from tertiary care centre in central India
Author’s name:
Pankaj Dwivedi MD1*, Kishor Deshpande MD2, Atul Kapse DNB1, Nitin Manvani DNB1, Nilesh Dhole MSc3, Anand Pathak MD4
  1. Department of pediatric oncology National Cancer Institute Nagpur India
  2. Department of pathology, National Cancer Institute Nagpur India
  3. Department of onco-pathology Homi Bhabha Cancer Hospital Varanasi India
  4. Department of medical oncology National Cancer Institute Nagpur India
*Correspondence: Dr.Pankaj Dwivedi MD Consultant Pediatric Oncology National Cancer Institute Nagpur India.
Contact Number: +917122800400/+919284001655
E-mail address: drpankoo@gmail.com
Word count for Abstract: 157
Main text: 2006
Number of tables: 06
Running title: MRD level in children treated with non-mrd protocol
Key words: Acute lymphoblastic leukemia, minimal residual disease, risk factors, risk stratification
Abbreviations key